Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006, 150(2):333-338 | DOI: 10.5507/bp.2006.051

CISATRACURIUM VS. ROCURONIUM: A PROSPECTIVE, COMPARATIVE, RANDOMIZED STUDY IN ADULT PATIENTS UNDER TOTAL INTRAVENOUS ANAESTHESIA

Milan Adamusa, Radim Belohlavekb, Jirina Koutnaa, Mariana Vujcikovaa, Eva Janaskovaa
a Department of Anaesthesiology and Intensive Care Medicine, University Hospital and Faculty of Medicine, Palacky University, Olomouc, Czech Republic
b Department of Computer Science, Palacky University, Olomouc, Czech Republic

Aims: To compare the pharmacodynamics of cisatracurium and rocuronium-induced neuromuscular block following single dose, allowing either spontaneous or neostigmine-accelerated complete recovery.

Methods: Following the ethics committee approval and informed consent, 120 patients scheduled for elective surgery under TIVA with tracheal intubation were randomized into 4 groups with different cisatracurium (CIS, 0.10 or 0.15 mg.kg-1) or rocuronium (ROC, 0.60 or 0.90 mg.kg-1) doses administered. For each patient, the onset time for 95 % depression of T1, clinical duration until 25 % recovery, recovery index (T1 from 25 to 75 %) and time from T1 25 % to TOF-ratio 0.9 were determined allowing either spontaneous or induced recovery.

Results: The onset times were 277 (SD 58), 220 (46), 91 (16) and 77 (16) s for the CIS 0.10, CIS 0.15, ROC 0.60 and ROC 0.90 groups (p < 0.05), respectively, with lower variability in both ROC groups (p < 0.05). The clinical durations were 42 (7), 52 (7), 35 (11) and 52 (12) min, respectively (p < 0.05 for lower doses). Recovery index was identical in all groups allowing either spontaneous recovery - 15.9 (1.8), 15.5 (1.7), 16.1 (3.7) and 16.1 (4.0) min, or following neostigmine administration - 4.4 (0.9), 4.5 (0.8), 4.3 (0.8) and 4.7 (0.7) min for respective groups. During spontaneous recovery, the variability of DUR25-TOF90 was twice as great for ROC than CIS groups (p < 0.05), while after neostigmine administration it was uniform in all groups.

Conclusions: For equipotent doses, the onset times for CIS were approximately three times longer than for ROC. The average clinical duration for both relaxants ranged from 35 to 52 min with acceptable variability. Neostigmine administration accelerated the recovery and reduced its variability. When allowing for spontaneous recovery, less scatter was demonstrated for both CIS groups than for ROC ones.

Keywords: Neuromuscular block, Cisatracurium, Rocuronium, Clinical duration, Onset time, Recovery index

Received: October 20, 2006; Accepted: November 10, 2006; Published: December 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Adamus, M., Belohlavek, R., Koutna, J., Vujcikova, M., & Janaskova, E. (2006). CISATRACURIUM VS. ROCURONIUM: A PROSPECTIVE, COMPARATIVE, RANDOMIZED STUDY IN ADULT PATIENTS UNDER TOTAL INTRAVENOUS ANAESTHESIA. Biomedical papers150(2), 333-338. doi: 10.5507/bp.2006.051
Download citation

References

  1. Iwasaki H. An overview of the pharmacokinetics and pharmacodynamics of rocuronium bromide. Masui 2006; 55:82633.
  2. Herold I. Muscle relaxants in anaesthesiology and intensive care medicine (in Czech). 1st ed. Prague: Maxdorf; 2004.
  3. Evers AS, Maze M. Anesthetic Pharmacology. Physiological Principles and Clinical Practice: A Companion to Millers Anesthesia. 1st ed. Philadelphia, Pennsylvania: Elsevier; 2004.
  4. Mallampati SR, Gatt SP, Gugino LD, Desai SP, Waraksa B, Freiberger D, Liu PL. A clinical sign to predict difficult tracheal intubation: a prospective study. Can Anaesth Soc J 1985; 32:429 34. Go to original source... Go to PubMed...
  5. References and formulas used by the Body Surface Area Calculator. Formula for Body Mass Index. Formulas for Body Surface Area [on line] [cited 2006 Sept 18]. Available from http://www.halls. md/body-surface-area/refs.htm
  6. Servin F, Cazalaa JB, Levron JC. Propofol, Sufentanil, Remifentanil in TCI. Bibliographical study of anesthetic agents used in the Base Primea, Fresenius Vial. Le Grand Chemin, Brezins: Fresenius Vial, 2003.
  7. Viby-Mogensen J, Engbaek J, Eriksson LI, Gramstad L, Jensen E, Jensen FS. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40:5974. Go to original source... Go to PubMed...
  8. Viby-Mogensen J, Ostergaard D, Donati F, Fisher D, Hunter J, Kampmann JP. Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP). Acta Anaesthesiol Scand 2000; 44:116990. Go to original source... Go to PubMed...
  9. Adamus M, Adamus P, Belohlavek R, Vujcikova M, Janaskova E. The impact of different rocuronium doses on its pharmacodynamic profile: a prospective study. Anest Intenziv Med 2004; 15:269 75.
  10. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 19992000. Anesthesiology 2003; 99:53645. Go to original source... Go to PubMed...
  11. Baillard C, Korinek AM, Galanton V et al. Anaphylaxis to rocuronium. Br J Anaesth 2002; 88, 6002. Go to original source... Go to PubMed...
  12. Brozovic G, Kvolik S. Anaphylactic reaction after rocuronium. Eur J Anaesthesiol 2005; 22:723. Go to original source... Go to PubMed...
  13. Harboe T, Guttormsen AB, Irgens A, Dybendal T, Florvaag E. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005; 102:897903. Go to original source... Go to PubMed...
  14. Bhananker SM, ODonnell JT, Salemi JR, Bishop MJ. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events. Anesth Analg 2005; 101:81922. Go to original source... Go to PubMed...
  15. Laake JH, Rottingen JA. Rocuronium and anaphylaxis-a statistical challenge. Acta Anaesthesiol Scand 2001; 45:11961203. Go to original source... Go to PubMed...
  16. Watkins J. Incidence of UK reactions involving rocuronium may simply reflect market use. Br J Anaesth 2001; 87:522.
  17. Lagneau F, Corda B, Marty J. Possible underestimation of the relative incidence of anaphylactic reactions to benzylisoquinoline neuromuscular blocking agents. Eur J Anaesthesiol 2003; 20:5778. Go to original source... Go to PubMed...
  18. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84:3945. Go to original source... Go to PubMed...
  19. Cammu G, de Baerdemaeker L, den Blauwen N, de Mey JC, Struys M, Mortier E. Postoperative residual curarization with cisatracurium and rocuronium infusions. Eur J Anaesthesiol 2002; 19:129 34. Go to original source... Go to PubMed...
  20. Beaussier M, Boughaba MA. Residual neuromuscular blockade. Ann Fr Anesth Reanim 2005; 24:126674. Go to original source... Go to PubMed...
  21. Viby-Mogensen J. Postoperative residual curarization and evidencebased anaesthesia. Br J Anaesth 2000; 84:3013. Go to original source... Go to PubMed...
  22. Gatke MR, Viby-Mogensen J, Rosenstock C, Jensen FS, Skovgaard LT. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand 2002; 46:20713. Go to original source... Go to PubMed...
  23. Kopman AF, Zank LM, Ng J, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory? Anesth Analg 2004; 98:1026. Go to original source... Go to PubMed...
  24. Sluga M, Ummenhofer W, Studer W, Siegemund M, Marsch SC. Rocuronium versus succinylcholine for rapid sequence induction of anesthesia and endotracheal intubation: a prospective, randomized trial in emergent cases. Anesth Analg 2005; 101:135661. Go to original source... Go to PubMed...
  25. Perry J, Lee J, Wells G. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2003, (1):CD002788. Go to original source... Go to PubMed...
  26. Ortiz-Gomez JR, Carrascosa F, Perez-Cajaraville JJ, Percaz-Bados JA, Anez C. Comparative study of intubating conditions at the first minute with suxamethonium, rocuronium and different priming techniques of rocuronium. Eur J Anaesthesiol 2005; 22:2638. Go to original source... Go to PubMed...
  27. Adamus M, Belohlavek R. Fuzzy control of neuromuscular block during general anesthesia system design, development and implementation. International Journal of General Systems 2006; to appear. Go to original source...
  28. Melloni C, Devivo P, Launo C, Mastronardi P, Novelli GP, Romano E. Cisatracurium versus vecuronium: a comparative, double blind, randomized, multicenter study in adult patients under propofol/ fentanyl/N2O anesthesia. Minerva Anestesiol 2006; 72:299308.
  29. Hans P, Welter P, Dewandre PY, Brichant JF, Bonhomme V. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery. Acta Anaesthesiol Belg 2004; 55:12933. Go to original source...
  30. Naguib M, Riad W. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block. Can J Anaesth 2000; 47:107481. Go to original source...
  31. Jellish WS, Brody M, Sawicki K, Slogoff S. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofolbased anesthetics. Anesth Analg 2000; 91:12505. Go to original source...
  32. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:10428. Go to original source... Go to PubMed...
  33. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56:3128. Go to original source... Go to PubMed...